HOME >> BIOLOGY >> NEWS
Prior caesarean delivery not linked to increased risk of stillbirth

Women with a history of caesarean section deliveries do not have a higher risk of a subsequent stillbirth, according to researchers at Yale School of Medicine and Columbia University.

Yale Obstetrics and Gynecology scientist Mert Ozan Bahtiyar, M.D., presented the findings today at the annual meeting of the Society for Maternal Fetal Medicine, held February 7-12 in Reno, Nevada.

"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.

Fetal death or stillbirth is an underappreciated problem, according to Bahtiyar, who said that stillbirths account for more perinatal deaths than do complications of prematurity or sudden infant death syndrome. Some risk factors for stillbirth include history of a prior stillbirth, a mother over the age of 35, smoking, substance abuse, and underlying medical conditions such as diabetes, hypertension or preeclampsia. A previous study by researchers in England found that prior caesarean delivery was also a factor in increased risk of stillbirth.

Bahtiyar and his team decided to confirm the previous study using U.S. data from the Centers for Disease Control and Prevention's combined birth and death certificates from 1995 to 1997. They used a statistical analysis method called Cochran-Mantel-Haenszel to determine the odds of fetal death after prior caesarean section.

"We used a much larger data set of 250,000 patients than the British study, which used 16,000 patients," said Bahtiyar. "We were not expecting different results, but we found that prior caesarean section did not increase the risk of future stillbirth."

Co-authors included Joshua Copel, M.D., Charles J. Lockwood, M.D., and Errol R. Norwitz, M.D., of Yale; and Julian Robinson, M.D., Lambert Lumey, M.D., and Patricia Zybert, M.D., of Columbia.
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
12-Feb-2005


Page: 1 2

Related biology news :

1. Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
2. Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model
3. New designer lipid-like peptide with lipid nanostructures for drug delivery systems
4. Alcohol use during pregnancy leads to greater risk of extreme preterm delivery
5. BEMA Fentanyl demonstrates substantial transmucosal delivery
6. Little lifesavers -- Nanoparticles improve delivery of medicines and diagnostics
7. Polymers show promise for gene delivery, tissue scaffolds, other biomedical applications
8. Nanoparticles for delivery of prostate cancer treatment
9. LED array signals successful binding of drug-delivery molecules to DNA
10. Pregnancy news -- Preterm delivery risk reduced by high-dose progesterone treatment
11. ResearchChannel expands delivery for its extensive online video library

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... Research and Markets has announced the addition ... their offering. ... tracking market to grow at a CAGR of 30.37% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... 13 prestigious awards honoring scientists who have made outstanding contributions ... scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory ...
(Date:10/9/2017)... ... 2017 , ... The Giving Tree Wellness Center announces the ... of consumers who are incorporating medical marijuana into their wellness and health regimens. ... operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach Mazor ...
Breaking Biology Technology:
Cached News: